Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

Abstract

The safety, tolerability, and pharmacokinetics of an oral solution of itraconazole and its active metabolite hydroxyitraconazole were investigated in an open multicenter study of 26 infants and children aged 6 months to 12 years with documented mucosal fungal infections or at risk for the development of invasive fungal disease. The most frequent underlying… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.